About MedWorks

This author has not yet filled in any details.
So far MedWorks has created 121 blog entries.

Reseña educativa

By |2007-08-01T23:13:14-07:00August 1st, 2007|MedWorks, Psiquiatría y Salud Integral, We Know Psychiatry|

Therapeutic and diagnostic ADHD Guide - Part I Dr. Peter S. Jensen and Ms. Maura Crowe   Background disorder attention deficit hyperactivity disorder (ADHD) is the most common behavioral / emotional disorder among school-age children and adolescents. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (Diagnostic and Statistical [...]

Caso clínico

By |2007-08-01T23:10:12-07:00August 1st, 2007|MedWorks, Psiquiatría y Salud Integral, We Know Psychiatry|

Delirium Trihexyphenidyl Hydrochloride Dr. Andres and Dr. Jaime Solis Heerlein   Summary For a patient of 17 years old, single, student, who is taken by her parents to consult the emergency service by behavioral problems, disorientation, paranoid and suicidal ideation, secondary use of trihexyphenidyl hydrochloride associated with consumption is presented [...]

Caso clínico

By |2007-08-01T23:08:10-07:00August 1st, 2007|MedWorks, Psiquiatría y Salud Integral, We Know Psychiatry|

Light therapy for seasonal depressive disorder Dr. Andrés Heerlein   Introduction Since the work of Rosenthal and colleagues1 pioneers of seasonal affective disorder (SAD) and phototherapy, many authors have stressed the need to include this kind of therapeutic tool in the treatment guidelines disorders ánimo.1-3 Light therapy was first introduced [...]

Psychopharmacology Bulletin Newsletter 3

By |2007-06-09T20:45:45-07:00June 9th, 2007|Brief Bulletins from the Field, MedWorks, We Know Psychiatry|

2007 Edition, N. 3    MEDWORKS    Vol. 40 - No. 2 - 2007 ------------------------------------------------------------------------ THE TRIALS AND TRIBULATIONS OF ARIPIPRAZOLE The objective of the study was to assess the efficacy and safety of aripiprazole in outpatients with post traumatic stress disorder (PTSD) on a 12-week, open-label trial. Twenty-two subjects with DSM-IV [...]

EDITORIALS

By |2007-05-03T22:48:16-07:00May 3rd, 2007|MedWorks, We Know Psychiatry|

Pharmaceutical Complex Zyban Rising: Smokers Thwart Insurance Carriers But Get What They Pay for By James La Rossa Jr. While the latest smoking cessation therapy utilizing the compound Zyban is making the rounds of newspapers and television news programs, its identical twin, bupropion, or Wellbutrin SR, is getting the lion’s [...]

EDITORIALS

By |2007-05-03T22:36:20-07:00May 3rd, 2007|MedWorks, We Know Psychiatry|

Point & Commentary Physicians Back in the Driver’s Seat By James M. La Rossa Jr. At the beginning of 1997, the seasoned CBS newsman, Mike Wallace, and his wife Mary, sat for a portrait cover of the first Mental Fitness Consumer edition.1 Wallace’s honest disclosure about his suicidal depression was [...]

EDITORIALS

By |2007-05-03T22:23:28-07:00May 3rd, 2007|MedWorks, We Know Psychiatry|

Guest Editorial A u t i s m : A Personal Insight B y  T e m ple G r a n d i n , P h D W hen I wa s 3, I had a ll the sy mptoms of autism— no speech, tantrums, self-stimulatory behavior, and [...]

EDITORIALS

By |2007-05-03T22:20:21-07:00May 3rd, 2007|MedWorks, We Know Psychiatry|

EDITOR’S NOTE The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry By Michael E. Thase, MD It is both an honor and a ch a llenge to assume the helm as editor of P sy ch o p h a rm ac o l [...]

Psychopharmacology Bulletin Newsletter

By |2007-05-03T02:53:08-07:00May 3rd, 2007|We Know Psychiatry|

2007 Edition, N. 2    ORIGINAL RESEARCH    Vol. 39 No. 1 - Vol. 40, No. 1 ------------------------------------------------------------------------ IS ANTIDEPRESSANT SELECTION RATIONAL? Every clinician faces the daily question of which antidepressant is best for a particular depressed patient. Double-blind studies submitted for U.S. Federal Drug Administration marketing approval include only the “purest” [...]

Psychopharmacology Bulletin Newsletters

By |2007-05-02T18:39:48-07:00May 2nd, 2007|Brief Bulletins from the Field, MedWorks, We Know Psychiatry|

2007 Edition, N. 1    ORIGINAL RESEARCH    Vol. 39 No. 1 - Vol. 40, No. 1 ------------------------------------------------------------------------ DEBATING PSYCHOTROPICS AND SUICIDALITY Until now, it has been unclear if the suicide risk is significantly different among clinical trial patients assigned to psychotropic, compared with patients assigned to placebo. Researchers examine - in [...]

Go to Top